Efficacy of chemotherapy plus cetuximab according to metastatic site in KRAS wild-type metastatic colorectal cancer (mCRC): Analysis of CRYSTAL and OPUS studies.
C. Kohne
Honoraria - Amgen; Merck KGaA; Pfizer
Research Funding - Amgen; GlaxoSmithKline; Merck KGaA; Pfizer; Roche
C. Bokemeyer
Consultant or Advisory Role - Merck Serono
Honoraria - Merck Serono
Research Funding - Merck Serono
Other Remuneration - Merck Serono
S. Heeger
Employment or Leadership Position - Merck KGaA
U. Sartorius
Employment or Leadership Position - Merck KGaA
P. Rougier
Consultant or Advisory Role - Merck KGaA
E. Van Cutsem
Consultant or Advisory Role - Merck Serono
Research Funding - Merck Serono